Medical Equipment

High-Fidelity Long-Read Sequencing Market Forecast: How Big Will It Be by 2030?

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the high-fidelity long-read sequencing market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the High-Fidelity Long-Read Sequencing Market?

The high-fidelity long-read sequencing market has experienced rapid expansion over recent years. It is projected to increase from $1.53 billion in 2025 to $1.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.2%. Historically, this growth was driven by advancements in sequencing chemistry accuracy, early adoption in genomics research institutions, expansion of large-scale genome projects, increasing demand for structural variant analysis, and improvements in sequencing hardware performance.

The high-fidelity long-read sequencing market is projected to experience rapid expansion in the coming years, with its valuation anticipated to reach $4.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.5%. This growth during the projected timeframe can be ascribed to factors such as the increasing application of precision medicine approaches, heightened investments in genomics-based drug discovery, the expansion of rare disease research, greater clinical integration of long-read sequencing, and advancements in sequencing cost efficiency. Key trends for this period encompass the wider implementation of long-read sequencing in clinical diagnostics, an escalating need for high-accuracy variant detection, the expanding utilization of de novo genome assembly techniques, the broadening scope of epigenetic and transcriptomic analysis applications, and improved incorporation of sophisticated bioinformatics tools.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp

Which Drivers Are Supporting The Rise Of The High-Fidelity Long-Read Sequencing Market?

The increasing occurrence of rare diseases is anticipated to boost the expansion of the HiFi long-read sequencing market in the future. These disorders affect a small population, typically presenting with intricate symptoms and few therapeutic avenues. The rise in rare diseases can be attributed to advancements in genetic sequencing and diagnostic methods, facilitating earlier and more precise identification of conditions previously overlooked or incorrectly categorized. HiFi long-read sequencing plays a crucial role in tackling rare diseases by allowing for highly accurate, all-encompassing detection of intricate genetic variations frequently overlooked by short-read sequencing, thereby resulting in quicker and more accurate diagnoses. For example, as reported by the Department of Health & Social Care, a UK-based government department, in July 2023, there are an estimated more than 7,000 rare diseases, with new ones continuously being identified through ongoing research. It is understood that around 80% of these rare diseases have a genetic foundation. This growing occurrence of rare diseases is, therefore, fueling the development of the HiFi long-read sequencing market.

What Leading Segments Are Studied In The High-Fidelity Long-Read Sequencing Market?

The high-fidelity long-read sequencing market covered in this report is segmented –

1) By Product Type: Instruments; Consumables; Software

2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies

3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications

4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments

2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes

3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software

Which Market Trends Are Opening Growth Opportunities In The High-Fidelity Long-Read Sequencing Market?

Major companies operating within the HiFi long-read sequencing market are concentrating on developing innovative solutions, such as hybrid-capture target enrichment, to enhance sequencing accuracy, increase coverage of complex genomic regions, and accelerate the detection of structural variants for advanced research and clinical applications. Hybrid-capture target enrichment denotes a genomic sequencing technique that selectively isolates specific regions of DNA or RNA from a sample using complementary probes, enabling focused, high-accuracy sequencing of target regions while reducing the sequencing of non-relevant regions. For instance, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, introduced QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) offerings. This product utilizes hybrid-capture enrichment to facilitate precise long-read sequencing of intricate genomic regions like repeats and structural variants, thereby overcoming short-read limitations. They offer exceptional uniformity, specificity, and comprehensive coverage for applications in cancer profiling, HLA typing, and haplotype phasing, with flexible fixed or custom formats and integrated workflows from DNA prep to bioinformatics analysis, providing streamlined efficiency and deeper insights for precision medicine.

Which Major Firms Are Strengthening Their Position In The High-Fidelity Long-Read Sequencing Market?

Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report

Which Region Shows The Strongest Potential For Future Expansion In The High-Fidelity Long-Read Sequencing Market?

North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized High-Fidelity Long-Read Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33166&type=smp

Browse Through More Reports Similar to the Global High-Fidelity Long-Read Sequencing Market 2026, By The Business Research Company

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Short Read Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

Clinical Oncology Next Generation Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795